Authors:
Borchmann, P
Schnell, R
Knippertz, R
Staak, JO
Camboni, GM
Bernareggi, A
Hubel, K
Staib, P
Schulz, A
Diehl, V
Engert, A
Citation: P. Borchmann et al., Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma, ANN ONCOL, 12(5), 2001, pp. 661-667
Citation: K. Hubel et al., Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases, J INFEC DIS, 183(2), 2001, pp. 321-328
Authors:
Hubel, K
Mansmann, G
Schafer, H
Oberhauser, F
Diehl, V
Engert, A
Citation: K. Hubel et al., Increase of anti-inflammatory cytokines in patients with esophageal cancerafter perioperative treatment with G-CSF, CYTOKINE, 12(12), 2000, pp. 1797-1800
Authors:
Schafer, H
Hubel, K
Bohlen, H
Mansmann, G
Hegener, K
Richarz, B
Oberhauser, F
Wassmer, G
Holscher, AH
Pichlmaier, H
Diehl, V
Engert, A
Citation: H. Schafer et al., Perioperative treatment with Filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy, ANN HEMATOL, 79(3), 2000, pp. 143-151
Authors:
Schafer, H
Mansmann, G
Grass, G
Hubel, K
Holscher, AH
Engert, A
Citation: H. Schafer et al., Improvement of the reduced postoperative granulocyte function by G-CSF in patients with esophageal cancer, LANG ARCH S, 1999, pp. 23-27
Authors:
Hubel, K
Hegener, K
Schnell, R
Mansmann, G
Oberhauser, F
Staib, P
Diehl, V
Engert, A
Citation: K. Hubel et al., Suppressed neutrophil function as a risk factor for severe infection aftercytotoxic chemotherapy in patients with acute nonlymphocytic leukemia, ANN HEMATOL, 78(2), 1999, pp. 73-77